Plant extracts remain central to antidiabetic discovery because their phytochemicals influence biochemical, cellular and physiological pathways linked with glucose regulation. These preparations inhibit digestive enzymes, modulate insulin-linked signalling, reduce oxidative stress, suppress inflammatory mediators and support β-cell resilience. Reported activity depends on methodological design and assay calibration. Recent advances strengthened early evaluation through refined in vitro enzyme assays, glucose handling models and calibrated cellular platforms. In vivo studies provide clearer evidence of glycaemic modulation, lipid correction and tissue protection when dosing and induction conditions are reported with full transparency. In silico systems reinforce laboratory findings through predicted multi-target binding profiles and ligand-stability modelling. Multi-omics technologies deepen mechanistic interpretation by mapping metabolite shifts, transcriptional responses and proteomic patterns that connect extract chemistry with metabolic outcomes. Integrated workflows now combine chemical profiling with in vitro, in vivo and computational systems to enhance reproducibility and improve mechanistic resolution across methodological tiers. Persistent challenges include extraction heterogeneity, assay variability, incomplete standardisation and uncertainty regarding model translatability across experimental tiers. This review examines methodological and mechanistic advances that strengthen the reliability and interpretability of plant-derived antidiabetic research.
- Open Access
- Review
Methodological and Mechanistic Advances in Evaluating the Antidiabetic Activity of Plant Extracts
Author Information
Received: 24 Feb 2026 | Revised: 06 Apr 2026 | Accepted: 15 Apr 2026 | Published: 30 Apr 2026
Abstract
Keywords
antidiabetic-assessment methodologies | plant-extract evaluation | phytochemical profiling | multi-omics analysis | methodological standardisation
References
- 1.
Shaw, J.E.; Sicree, R.A.; Zimmet, P.Z. Global estimates of diabetes prevalence for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87, 4–14. https://doi.org/10.1016/j.diabres.2009.10.007.
- 2.
Rahman, M.M.; Dhar, P.S.; Sumaia, S.; et al. Plant-derived bioactive substances as antidiabetic agents: An extensive review. Biomed. Pharmacother. 2022, 152, 113217. https://doi.org/10.1016/j.biopha.2022.113217.
- 3.
Alam, S.; Sarker, M.M.R.; Sultana, T.N.; et al. Antidiabetic phytochemicals from medicinal plants: Prospective candidates for new drug discovery and development. Front. Endocrinol. 2022, 13, 800714. https://doi.org/10.3389/fendo.2022.800714.
- 4.
Situmorang, P.C.; Zuhra, C.F.; Lutfia, A.; et al. Harnessing phytochemicals to combat diabetes: Insights into molecular pathways and therapeutic advances. J. Funct. Foods 2025, 128, 106799. https://doi.org/10.1016/j.jff.2025.106799.
- 5.
Al-Romaiyan, A.; Liu, B.; Asare Anane, H.; et al. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro. Phytother. Res. 2010, 24, 1370–1376. https://doi.org/10.1002/ptr.3125.
- 6.
Mahmood, R.; Kayani, W.K.; Ahmed, T.; et al. Antidiabetic potential and phytochemical profiling of Rhazya stricta root extracts. BMC Complement. Med. Ther. 2020, 20, 293. https://doi.org/10.1186/s12906-020-03035-x.
- 7.
Yang, J.; Seo, H.-J.; Wang, Y.; et al. Antioxidant potential and in vitro antidiabetic activity of Paeonia japonica extract and isolated compounds. Agronomy 2024, 14, 2705. https://doi.org/10.3390/agronomy14112705.
- 8.
Laaraj, N.; Bouhrim, M.; Kharchoufa, L.; et al. Phytochemical analysis, α-glucosidase and α-amylase inhibitory activities and acute toxicity studies of extracts from pomegranate (Punica granatum) bark, a valuable agro-industrial by-product. Foods 2022, 11, 1353. https://doi.org/10.3390/foods11091353.
- 9.
Benayad, O.; Bouhrim, M.; Tiji, S.; et al. Phytochemical profile, α-glucosidase and α-amylase inhibition potential and toxicity evaluation of extracts from Citrus aurantium (L.) peel, a valuable by-product from Northeastern Morocco. Biomolecules 2021, 11, 1555. https://doi.org/10.3390/biom11111555.
- 10.
Abomughaid, M.M.; El Shibani, F.A.A.; Abdulkarim, A.K.; et al. Phytochemical profiling, in vitro and in vivo antidiabetic activity, and in silico studies on Ajuga iva (L.) Schreb. Open Chem. 2024, 22, 20230191. https://doi.org/10.1515/chem-2023-0191.
- 11.
Saidi, S.; Remok, F.; Handaq, N.; et al. Phytochemical profile, antioxidant, antimicrobial and antidiabetic activities of Ajuga iva (L.). Life 2023, 13, 1165. https://doi.org/10.3390/life13051165.
- 12.
Sukhtezari, S.; Sahari, M.A.; Barzegar, M.; et al. In vitro antidiabetic and antioxidant activities of Galega officinalis extracts. Food Sci. Nutr. 2024, 12, 8137–8149. https://doi.org/10.1002/fsn3.4326.
- 13.
Zehra, S.A.; Bhattarai, P.; Zhang, J.; et al. In vitro and in vivo evaluation of the antidiabetic activity of Solidago virgaurea extracts. Curr. Bioact. Compd. 2022, 19, e150622206034. https://doi.org/10.2174/1573407218666220615143502.
- 14.
Ardalani, H.; Hejazi Amiri, F.; Hadipanah, A.; et al. Potential antidiabetic phytochemicals in plant roots: A review of in vivo studies. J. Diabetes Metab. Disord. 2021, 20, 1837–1854. https://doi.org/10.1007/s40200-021-00853-9.
- 15.
Bashkin, A.; Ghanim, M.; Abu Farich, B.; et al. Forty-one plant extracts screened for dual antidiabetic and antioxidant functions: Evaluating the types of correlation between α-amylase inhibition and free radical scavenging. Molecules 2021, 26, 317. https://doi.org/10.3390/molecules26020317.
- 16.
Kidane, Y.; Bokrezion, T.; Mebrahtu, J.; et al. In vitro inhibition of α-amylase and α-glucosidase by extracts from Psiadia punctulata and Meriandra bengalensis. Evid. Based Complement. Alternat. Med. 2018, 2018, 2164345. https://doi.org/10.1155/2018/2164345.
- 17.
Mokhtari, M.; Chabani, S.; Mouffouk, S.; et al. Phytochemicals, antihemolytic, anti-inflammatory, antioxidant, and antibacterial activities from Thymus algeriensis. J. Liq. Chromatogr. Relat. Technol. 2021, 44, 253–266. https://doi.org/10.1080/10496475.2021.1891174.
- 18.
Paun, G.; Neagu, E.; Albu, C.; et al. In vitro antidiabetic and anti-inflammatory activities of polyphenolic-rich extracts from Anchusa officinalis and Melilotus officinalis. ACS Omega 2020, 5, 13014–13022. https://doi.org/10.1021/acsomega.0c00929.
- 19.
Wakene, W.; Asmamaw, S.; Kahaliw, W. Evaluation of antidiabetic and antioxidant activity of leaf extract and solvent fractions of Hypoestes forskaolii (Val) (Acanthaceae) in mice. J. Exp. Pharmacol. 2021, 13, 859–872. https://doi.org/10.2147/JEP.S318696.
- 20.
Belayneh, Y.M.; Birhanu, Z.; Birru, E.M.; et al. Evaluation of in vivo antidiabetic, antidyslipidemic, and in vitro antioxidant activities of hydromethanolic root extract of Datura stramonium L. (Solanaceae). J. Exp. Pharmacol. 2019, 11, 29–38. https://doi.org/10.2147/JEP.S192264.
- 21.
He, D.; Cui, C. Plant heteropolysaccharides as potential anti-diabetic agents: A review. Curr. Issues Mol. Biol. 2025, 47, 533. https://doi.org/10.3390/cimb47070533.
- 22.
Pereira, A.S.P.; Banegas Luna, A.J.; Peña García, J.; et al. Evaluation of the anti-diabetic activity of common herbs and spices: Providing new insights with inverse virtual screening. Molecules 2019, 24, 4030. https://doi.org/10.3390/molecules24224030.
- 23.
Goulas, V.; Banegas Luna, A.J.; Constantinou, A.; et al. Computational screening of multi-target antidiabetic properties of phytochemicals in Mediterranean plants. Plants 2022, 11, 1637. https://doi.org/10.3390/plants11131637.
- 24.
Kumar, V.; Sharma, N.; Mishra, V.K.; et al. Computational evaluation of phytocompounds from selective medicinal plants as potential antidiabetic agents. Chem. Biodivers. 2025, 22, e202403368. https://doi.org/10.1002/cbdv.202403368.
- 25.
Kannan, K.; George, J.A.; Sahadevan, R.; et al. Insights into one drug, multi-target aspects of polyphenols for diabetes management: In vitro, in vivo and clinical evidence. Phytochem. Rev. 2025, 24, 4545–4593. https://doi.org/10.1007/s11101-024-10047-9.
- 26.
Shahidi, F.; Danielski, R. Review on the role of polyphenols in preventing and treating type 2 diabetes: Evidence from in vitro and in vivo studies. Nutrients. 2024, 16, 3159. https://doi.org/10.3390/nu16183159.
- 27.
Odeyemi, S.; Dewar, J. In vitro antidiabetic activity affecting glucose uptake in HepG2 cells exposed to Lauridia tetragona extracts. Processes 2020, 8, 33. https://doi.org/10.3390/pr8010033.
- 28.
Yikna, B.B.; Yehualashet, A.S. Medicinal plant extracts evaluated in vitro and in vivo for antidiabetic activities in ethiopia: Bases for future clinical trials and related investigations. Evid.-Based Complement. Alternat. Med. 2021, 2021, 9108499. https://doi.org/10.1155/2021/9108499.
- 29.
Mueed, A.; Shibli, S.; Al-Quwaie, D.A.; et al. Extraction and characterization of polyphenols from certain medicinal plants and evaluation of their antioxidant, antitumor, antidiabetic and antimicrobial properties and potential use in human nutrition. Front. Nutr. 2023, 10, 1125106. https://doi.org/10.3389/fnut.2023.1125106.
- 30.
Aryal, D.; Joshi, S.; Thapa, N.K.; et al. Dietary phenolic compounds as promising therapeutic agents for diabetes and its complications: A comprehensive review. Food Sci. Nutr. 2024, 20, 3983. https://doi.org/10.1002/fsn3.3983.
- 31.
Martiniakova, M.; Sarocka, A.; Penzes, N.; et al. Protective role of dietary polyphenols in the management and treatment of type 2 diabetes mellitus. Nutrients. 2025, 17, 275. https://doi.org/10.3390/nu17020275.
- 32.
Gavanji, S.; Bakhtari, A.; Abdel-Latif, R.; et al. Experimental approaches for induction of diabetes mellitus and assessment of antidiabetic activity: An in vitro and in vivo methodological review. Fundam. Clin. Pharmacol. 2024, 38, 842–861. https://doi.org/10.1111/fcp.13009.
- 33.
Ahmad, M.A.; Bhat, S.H.; Iqra, Z.; et al. Unveiling the therapeutic potential: Metabolomics insights into medicinal plants and their antidiabetic effects. Curr. Food Sci. Tech. Rep. 2024, 2, 91–109. https://doi.org/10.1007/s43555-024-00022-y.
- 34.
Elbermawi, A.; Darwish, M.S.; Zaki, A.A.; et al. In vitro antidiabetic, antioxidant, and prebiotic activities of the chemical compounds isolated from Guizotia abyssinica. Antioxidants. 2022, 11, 2482. https://doi.org/10.3390/antiox11122482.
- 35.
Kifle, Z.D.; Yesuf, J.S.; Atnafie, S.A. Evaluation of in vitro and in vivo anti-diabetic, anti-hyperlipidemic, and antioxidant activity of flower crude extract and solvent fractions of Hagenia abyssinica (Rosaceae). J. Exp. Pharmacol. 2020, 12, 151–167. https://doi.org/10.2147/JEP.S249964.
- 36.
Ansari, P.; Flatt, P.R.; Harriott, P.; et al. Evaluation of the antidiabetic and insulin-releasing effects of Annona squamosa, including isolation and characterization of active phytochemicals. Plants 2020, 9, 1348. https://doi.org/10.3390/plants9101348.
- 37.
Agawane, S.B.; Gupta, V.S.; Kulkarni, M.J.; et al. Chemo-biological evaluation of antidiabetic activity of Mentha arvensis L. and its role in inhibition of advanced glycation end products. J. Ayurveda Integr. Med. 2019, 10, 166–170. https://doi.org/10.1016/j.jaim.2017.07.003.
- 38.
Neagu, E.; Paun, G.; Albu, C.; et al. In vitro assessment of the antidiabetic and anti-inflammatory potential of Artemisia absinthium, Artemisia vulgaris, and Trigonella foenum‑graecum extracts processed using membrane technologies. Molecules 2023, 28, 7156. https://doi.org/10.3390/molecules28207156.
- 39.
Rossafi, B.; Bouribab, A.; Abchir, O.; et al. Antidiabetic potential of Moroccan medicinal plant extracts: A virtual screening using in silico approaches. Results Chem. 2025, 16, 102365. https://doi.org/10.1016/j.rechem.2025.102365.
- 40.
Hussain, I.; Janjua, M.R.S.A.; Haq, A.U.; et al. Evaluation of anti-infection and anti-diabetic activities in methanolic and n-hexane plant extracts of indigenously cultivated Chenopodium album. Agronomy 2024, 14, 1340. https://doi.org/10.3390/agronomy14071340.
- 41.
Carvalho, I.S.; Viegas, C.; Markiewicz, M.; et al. Plant-based potential in diabetes management: In vitro antioxidant, wound-healing, and enzyme inhibitory activities of southern algarve species. Molecules 2025, 30, 2432. https://doi.org/10.3390/molecules30112432.
- 42.
Aljazzaf, B.; Regeai, S.; Elghmasi, S.; et al. Evaluation of antidiabetic effect of combined leaf and seed extracts of Moringa oleifera (Moringaceae) on alloxan-induced diabetes in mice: A biochemical and histological study. Oxid. Med. Cell. Longev. 2023, 2023, 9136217. https://doi.org/10.1155/2023/9136217.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Suite 4002 Level 4, 447 Collins Street, Melbourne, Victoria 3000, Australia
General Inquiries: info@sciltp.com